🇺🇸 FDA
Pipeline program

ARO-RAGE Injection

ARORAGE-1002

Phase 1 small_molecule completed

Quick answer

ARO-RAGE Injection for Asthma is a Phase 1 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ARROWHEAD PHARMACEUTICALS, INC.
Indication
Asthma
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials